Define techno-human convergence.
WeMake operates where living systems and engineered systems meet. Each capability is a path into techno-human convergence, plus full-service CRO support.
Carbon-first medicine. Strategic work across biologic drug development: target validation and CMC strategy through IND/BLA preparation, manufacturing partnerships, and global regulatory submissions. Our network has supported 100+ submissions to FDA, EMA, MHRA, and other agencies.
CRO & clinical →
Restoring living tissue and function. Program design, cell therapy partnerships, site and lab infrastructure, patient recruitment strategy, long-term follow-up, and commercialization pathways for advanced therapeutic products.
Super Nova MSCs → Download Brochure →
Where the carbon nervous system meets silicon interfaces. Brain-computer pathways, neurostimulation devices, wearable sensing, cognitive assessment protocols (including MoCA), and FDA/IDE regulatory design for neuromodulation and neuropsychiatric programs.
Related products →
Human intelligence with machine scale. Use-case design, model selection, data governance, MLOps infrastructure, workflow integration, and change management so artificial intelligence is safe, productive, and accountable.
Contact us →
Silicon-era engineering for extreme environments. Materials selection, thermal management, systems integration, test-stand design, and technology readiness (TRL) assessment for aerospace, defense, and advanced mobility applications.
Contact us →
Living interventions need rigorous trials. WeMake offers full-service Clinical Research Organization (CRO) and Site Management Organization (SMO) capabilities: 700+ studies delivered, 200+ collaborating sites, EDC and biostatistics depth, and global regulatory submissions from pre-IND through database lock.
Share your objectives at the techno-human edge. We will connect you with the right lead.
Contact us